- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The only guide for the public to the science and history of Alzheimer’s disease. This book can help you if you fear that you have Alzheimer’s disease or if a friend or family member has Alzheimer’s disease.
Andere Kunden interessierten sich auch für
- Abhilash K. DesaiHealthy Brain Aging: Evidence Based Methods to Preserve Brain Function and Prevent Dementia, an Issue of Clinics in Geriatric Medicine120,99 €
- John M. RingmanDementia, an Issue of Neurologic Clinics118,99 €
- Kathleen TaylorThe Fragile Brain26,99 €
- Cuthbert ChristyMosquitoes and Malaria: A Summary of Knowledge On the Subject Up to Date; With an Account of the Natural History of Some Mosquitoes35,99 €
- Susan OkieFed Up!25,99 €
- Endoscopic Follow-up of Digestive Anastomosis37,99 €
- Frederick M. AzarCampbell's Operative Orthopaedics, 4-Volume Set544,99 €
-
-
-
The only guide for the public to the science and history of Alzheimer’s disease. This book can help you if you fear that you have Alzheimer’s disease or if a friend or family member has Alzheimer’s disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Canbury Press
- Seitenzahl: 320
- Erscheinungstermin: 10. April 2025
- Englisch
- Abmessung: 234mm x 153mm x 27mm
- Gewicht: 450g
- ISBN-13: 9781914487422
- ISBN-10: 1914487427
- Artikelnr.: 71616387
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Canbury Press
- Seitenzahl: 320
- Erscheinungstermin: 10. April 2025
- Englisch
- Abmessung: 234mm x 153mm x 27mm
- Gewicht: 450g
- ISBN-13: 9781914487422
- ISBN-10: 1914487427
- Artikelnr.: 71616387
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
TABLE OF CONTENTS
Preface
Prologue
Part I – Alois & Auguste (and a bit of Oskar)
Chapter 1 – Dr Hoffmann’s vision
Chapter 2 – Mrs Deter
Chapter 3 – Alois Alzheimer
Chapter 4 – Munich via Heidelberg
Chapter 5 – 1906
Chapter 6 – The Tübingen aftermath
Chapter 7 – Fischer’s disease
Chapter 8 – Alzheimer’s legacy
Part I – Summary
Part II – Memory and Space
Chapter 9 – ‘You are not my type’
Chapter 10 – The art of memory
Chapter 11 – ‘Secret’ memory techniques
Chapter 12 – ‘Attention!’”
Chapter 13 – ‘Enter the seahorse’
Chapter 14 – Encoding, storage, retrieval
Chapter 15 – ‘It’s all about access’
Chapter 16 – The imaginary Mrs A
Chapter 17 – Spatial Disorientation
Chapter 18 – ‘Lost in space’
Part II – Summary
Part III – Amyloid and Tau
Chapter 19 – Glorious proteins
Chapter 20 – Amyloid
Chapter 21 – Beta-amyloid formation
Chapter 22 – ‘Location, location, location… and timing’
Chapter 23 – Tau
Chapter 24 – ‘Who ordered all the phosphate?’
Chapter 25 – Tau ‘infection’
Chapter 26 – Amyloid versus Tau
Chapter 27 – The ‘emergence’ of the disease
Chapter 28 – Biomarker technology
Chapter 29 – Amyloid treatment approaches
Decreasing beta-amyloid production
Prevention of beta-amyloid accumulation
Increase of beta-amyloid removal
Chapter 30 – Tau treatment approaches
Decrease of overall tau
Decrease of tau phosphorylation
Decrease phosphorylated tau accumulation
Increase phosphorylated tau removal
Chapter 31 – Why have drug trials failed so far?
Phase I
Phase II
Phase III
Part III – Summary
Part IV – Genetics and lifestyle
Chapter 32 – Genetics 101
Chapter 33 – Familial Alzheimer’s disease
APP
PSEN
MAPT
Chapter 34 – ‘Modifiable’ risk genes
APOE
TREM2
Chapter 35 – A word on genetic testing
Chapter 36 – Non-modifiable lifestyle factors
Age
Education
Hearing loss
Chapter 37 – Modifiable lifestyle factors
Diabetes, hypertension and obesity
Physical activity
Diet and nutrition
Sleep
Other modifiable lifestyle risk factors
Part IV – Summary
Part V – Rarer forms of Alzheimer’s disease
Chapter 38 – Frontal variant Alzheimer’s disease
Chapter 39 – Posterior Cortical Atrophy
Chapter 40 – Logopenic variant primary progressive aphasia
Chapter 41 – Corticobasal syndrome
Chapter 42 – A final word on the rarer forms of Alzheimer’s disease
Part V – Summary
Epilogue
Further country specific links (English language)
Index
Preface
Prologue
Part I – Alois & Auguste (and a bit of Oskar)
Chapter 1 – Dr Hoffmann’s vision
Chapter 2 – Mrs Deter
Chapter 3 – Alois Alzheimer
Chapter 4 – Munich via Heidelberg
Chapter 5 – 1906
Chapter 6 – The Tübingen aftermath
Chapter 7 – Fischer’s disease
Chapter 8 – Alzheimer’s legacy
Part I – Summary
Part II – Memory and Space
Chapter 9 – ‘You are not my type’
Chapter 10 – The art of memory
Chapter 11 – ‘Secret’ memory techniques
Chapter 12 – ‘Attention!’”
Chapter 13 – ‘Enter the seahorse’
Chapter 14 – Encoding, storage, retrieval
Chapter 15 – ‘It’s all about access’
Chapter 16 – The imaginary Mrs A
Chapter 17 – Spatial Disorientation
Chapter 18 – ‘Lost in space’
Part II – Summary
Part III – Amyloid and Tau
Chapter 19 – Glorious proteins
Chapter 20 – Amyloid
Chapter 21 – Beta-amyloid formation
Chapter 22 – ‘Location, location, location… and timing’
Chapter 23 – Tau
Chapter 24 – ‘Who ordered all the phosphate?’
Chapter 25 – Tau ‘infection’
Chapter 26 – Amyloid versus Tau
Chapter 27 – The ‘emergence’ of the disease
Chapter 28 – Biomarker technology
Chapter 29 – Amyloid treatment approaches
Decreasing beta-amyloid production
Prevention of beta-amyloid accumulation
Increase of beta-amyloid removal
Chapter 30 – Tau treatment approaches
Decrease of overall tau
Decrease of tau phosphorylation
Decrease phosphorylated tau accumulation
Increase phosphorylated tau removal
Chapter 31 – Why have drug trials failed so far?
Phase I
Phase II
Phase III
Part III – Summary
Part IV – Genetics and lifestyle
Chapter 32 – Genetics 101
Chapter 33 – Familial Alzheimer’s disease
APP
PSEN
MAPT
Chapter 34 – ‘Modifiable’ risk genes
APOE
TREM2
Chapter 35 – A word on genetic testing
Chapter 36 – Non-modifiable lifestyle factors
Age
Education
Hearing loss
Chapter 37 – Modifiable lifestyle factors
Diabetes, hypertension and obesity
Physical activity
Diet and nutrition
Sleep
Other modifiable lifestyle risk factors
Part IV – Summary
Part V – Rarer forms of Alzheimer’s disease
Chapter 38 – Frontal variant Alzheimer’s disease
Chapter 39 – Posterior Cortical Atrophy
Chapter 40 – Logopenic variant primary progressive aphasia
Chapter 41 – Corticobasal syndrome
Chapter 42 – A final word on the rarer forms of Alzheimer’s disease
Part V – Summary
Epilogue
Further country specific links (English language)
Index
TABLE OF CONTENTS
Preface
Prologue
Part I – Alois & Auguste (and a bit of Oskar)
Chapter 1 – Dr Hoffmann’s vision
Chapter 2 – Mrs Deter
Chapter 3 – Alois Alzheimer
Chapter 4 – Munich via Heidelberg
Chapter 5 – 1906
Chapter 6 – The Tübingen aftermath
Chapter 7 – Fischer’s disease
Chapter 8 – Alzheimer’s legacy
Part I – Summary
Part II – Memory and Space
Chapter 9 – ‘You are not my type’
Chapter 10 – The art of memory
Chapter 11 – ‘Secret’ memory techniques
Chapter 12 – ‘Attention!’”
Chapter 13 – ‘Enter the seahorse’
Chapter 14 – Encoding, storage, retrieval
Chapter 15 – ‘It’s all about access’
Chapter 16 – The imaginary Mrs A
Chapter 17 – Spatial Disorientation
Chapter 18 – ‘Lost in space’
Part II – Summary
Part III – Amyloid and Tau
Chapter 19 – Glorious proteins
Chapter 20 – Amyloid
Chapter 21 – Beta-amyloid formation
Chapter 22 – ‘Location, location, location… and timing’
Chapter 23 – Tau
Chapter 24 – ‘Who ordered all the phosphate?’
Chapter 25 – Tau ‘infection’
Chapter 26 – Amyloid versus Tau
Chapter 27 – The ‘emergence’ of the disease
Chapter 28 – Biomarker technology
Chapter 29 – Amyloid treatment approaches
Decreasing beta-amyloid production
Prevention of beta-amyloid accumulation
Increase of beta-amyloid removal
Chapter 30 – Tau treatment approaches
Decrease of overall tau
Decrease of tau phosphorylation
Decrease phosphorylated tau accumulation
Increase phosphorylated tau removal
Chapter 31 – Why have drug trials failed so far?
Phase I
Phase II
Phase III
Part III – Summary
Part IV – Genetics and lifestyle
Chapter 32 – Genetics 101
Chapter 33 – Familial Alzheimer’s disease
APP
PSEN
MAPT
Chapter 34 – ‘Modifiable’ risk genes
APOE
TREM2
Chapter 35 – A word on genetic testing
Chapter 36 – Non-modifiable lifestyle factors
Age
Education
Hearing loss
Chapter 37 – Modifiable lifestyle factors
Diabetes, hypertension and obesity
Physical activity
Diet and nutrition
Sleep
Other modifiable lifestyle risk factors
Part IV – Summary
Part V – Rarer forms of Alzheimer’s disease
Chapter 38 – Frontal variant Alzheimer’s disease
Chapter 39 – Posterior Cortical Atrophy
Chapter 40 – Logopenic variant primary progressive aphasia
Chapter 41 – Corticobasal syndrome
Chapter 42 – A final word on the rarer forms of Alzheimer’s disease
Part V – Summary
Epilogue
Further country specific links (English language)
Index
Preface
Prologue
Part I – Alois & Auguste (and a bit of Oskar)
Chapter 1 – Dr Hoffmann’s vision
Chapter 2 – Mrs Deter
Chapter 3 – Alois Alzheimer
Chapter 4 – Munich via Heidelberg
Chapter 5 – 1906
Chapter 6 – The Tübingen aftermath
Chapter 7 – Fischer’s disease
Chapter 8 – Alzheimer’s legacy
Part I – Summary
Part II – Memory and Space
Chapter 9 – ‘You are not my type’
Chapter 10 – The art of memory
Chapter 11 – ‘Secret’ memory techniques
Chapter 12 – ‘Attention!’”
Chapter 13 – ‘Enter the seahorse’
Chapter 14 – Encoding, storage, retrieval
Chapter 15 – ‘It’s all about access’
Chapter 16 – The imaginary Mrs A
Chapter 17 – Spatial Disorientation
Chapter 18 – ‘Lost in space’
Part II – Summary
Part III – Amyloid and Tau
Chapter 19 – Glorious proteins
Chapter 20 – Amyloid
Chapter 21 – Beta-amyloid formation
Chapter 22 – ‘Location, location, location… and timing’
Chapter 23 – Tau
Chapter 24 – ‘Who ordered all the phosphate?’
Chapter 25 – Tau ‘infection’
Chapter 26 – Amyloid versus Tau
Chapter 27 – The ‘emergence’ of the disease
Chapter 28 – Biomarker technology
Chapter 29 – Amyloid treatment approaches
Decreasing beta-amyloid production
Prevention of beta-amyloid accumulation
Increase of beta-amyloid removal
Chapter 30 – Tau treatment approaches
Decrease of overall tau
Decrease of tau phosphorylation
Decrease phosphorylated tau accumulation
Increase phosphorylated tau removal
Chapter 31 – Why have drug trials failed so far?
Phase I
Phase II
Phase III
Part III – Summary
Part IV – Genetics and lifestyle
Chapter 32 – Genetics 101
Chapter 33 – Familial Alzheimer’s disease
APP
PSEN
MAPT
Chapter 34 – ‘Modifiable’ risk genes
APOE
TREM2
Chapter 35 – A word on genetic testing
Chapter 36 – Non-modifiable lifestyle factors
Age
Education
Hearing loss
Chapter 37 – Modifiable lifestyle factors
Diabetes, hypertension and obesity
Physical activity
Diet and nutrition
Sleep
Other modifiable lifestyle risk factors
Part IV – Summary
Part V – Rarer forms of Alzheimer’s disease
Chapter 38 – Frontal variant Alzheimer’s disease
Chapter 39 – Posterior Cortical Atrophy
Chapter 40 – Logopenic variant primary progressive aphasia
Chapter 41 – Corticobasal syndrome
Chapter 42 – A final word on the rarer forms of Alzheimer’s disease
Part V – Summary
Epilogue
Further country specific links (English language)
Index